GT199700104AA - Procedimientos e intermedios para preparar derivados de cromanol sustituidos - Google Patents
Procedimientos e intermedios para preparar derivados de cromanol sustituidosInfo
- Publication number
- GT199700104AA GT199700104AA GT199700104AK GT199700104K GT199700104AA GT 199700104A A GT199700104A A GT 199700104AA GT 199700104A K GT199700104A K GT 199700104AK GT 199700104 K GT199700104 K GT 199700104K GT 199700104A A GT199700104A A GT 199700104AA
- Authority
- GT
- Guatemala
- Prior art keywords
- intermediates
- procedures
- chromanol derivatives
- substituted chromanol
- prepare substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/50—Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
ESTA INVENCION SE REFIERE A LA PREPARACION DE DERIVADOS DE CROMANOL SUSTITUIDOS Y A INTERMEDIOS UTILES EN DICHA PREPARACION. LOS DERIVADOS DE CROMANOL SUSTITUIDOS QUE SE PREPARAN DE ACUERDO CON LA PRESENTE INVENCION, INHIBEN LA ACCION DE LTB4. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA(V), EN LA QUE X,R1,R2,Y, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2637296P | 1996-09-16 | 1996-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT199700104AA true GT199700104AA (es) | 1999-03-28 |
Family
ID=21831429
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199700104A GT199700104A (es) | 1996-09-16 | 1997-09-08 | Procedimientos e intermedios para preparar derivados de cromanol sustituidos. |
| GT199700104BL GT199700104BA (es) | 1996-09-16 | 1997-10-04 | Procedimientos e intermedios para preparar derivados de cromanol sustituidos |
| GT199700104AK GT199700104AA (es) | 1996-09-16 | 1997-10-04 | Procedimientos e intermedios para preparar derivados de cromanol sustituidos |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199700104A GT199700104A (es) | 1996-09-16 | 1997-09-08 | Procedimientos e intermedios para preparar derivados de cromanol sustituidos. |
| GT199700104BL GT199700104BA (es) | 1996-09-16 | 1997-10-04 | Procedimientos e intermedios para preparar derivados de cromanol sustituidos |
Country Status (39)
| Country | Link |
|---|---|
| US (4) | US6096906A (es) |
| EP (1) | EP0925292B1 (es) |
| JP (1) | JP3117730B2 (es) |
| KR (1) | KR100339164B1 (es) |
| CN (1) | CN1108298C (es) |
| AP (1) | AP726A (es) |
| AT (1) | ATE249452T1 (es) |
| AU (1) | AU713701B2 (es) |
| BG (1) | BG63542B1 (es) |
| BR (1) | BR9711482A (es) |
| CA (1) | CA2265043C (es) |
| CO (1) | CO4600635A1 (es) |
| DE (1) | DE69724801T2 (es) |
| DK (1) | DK0925292T3 (es) |
| DZ (1) | DZ2308A1 (es) |
| EA (1) | EA002204B1 (es) |
| ES (1) | ES2206738T3 (es) |
| GT (3) | GT199700104A (es) |
| HN (1) | HN1997000127A (es) |
| HR (1) | HRP970497B1 (es) |
| ID (1) | ID19613A (es) |
| IL (1) | IL128732A0 (es) |
| IS (1) | IS4980A (es) |
| MA (1) | MA24319A1 (es) |
| NO (1) | NO991254L (es) |
| NZ (1) | NZ334214A (es) |
| OA (1) | OA10995A (es) |
| PA (1) | PA8437901A1 (es) |
| PE (1) | PE109798A1 (es) |
| PL (1) | PL332351A1 (es) |
| PT (1) | PT925292E (es) |
| SK (1) | SK31399A3 (es) |
| TN (1) | TNSN97155A1 (es) |
| TR (1) | TR199900592T2 (es) |
| TW (1) | TW449579B (es) |
| UA (1) | UA58520C2 (es) |
| WO (1) | WO1998011085A1 (es) |
| YU (1) | YU13299A (es) |
| ZA (1) | ZA978291B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436987B1 (en) * | 2000-06-08 | 2002-08-20 | Pfizer Inc. | Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid |
| WO2002060888A1 (en) * | 2001-01-30 | 2002-08-08 | Pfizer Products Inc. | Processes for preparing chromanylbenzoic acids |
| AU4239302A (en) * | 2001-06-28 | 2003-01-02 | Pfizer Products Inc. | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
| JP2010534240A (ja) | 2007-07-23 | 2010-11-04 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ | ボロン酸の反応性の調節系 |
| WO2010036921A2 (en) * | 2008-09-26 | 2010-04-01 | The Board Of Trustees Of The University Of Illinois | Slow release of organoboronic acids in cross-coupling reactions |
| US20110218319A1 (en) * | 2009-09-02 | 2011-09-08 | E. I. Du Pont De Nemours And Company | Polyaramid films comprising fluorovinylether functionalized aromatic moieties |
| CN102597060B (zh) * | 2009-09-02 | 2014-05-07 | 纳幕尔杜邦公司 | 包含氟乙烯基醚官能化芳族部分的芳族聚酰胺 |
| CN102612509A (zh) | 2009-09-02 | 2012-07-25 | 纳幕尔杜邦公司 | 氟醚官能化的芳族二酯及其衍生物 |
| KR20120092105A (ko) * | 2009-09-02 | 2012-08-20 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 개선된 발유성을 갖는 폴리에스테르 필름 |
| US8293928B2 (en) * | 2009-09-02 | 2012-10-23 | E I Du Pont De Nemours And Company | Fluorinated 4-oxo-chroman-7-carboxylates |
| IN2012DN01745A (es) * | 2009-09-02 | 2015-06-05 | Du Pont | |
| WO2011103435A2 (en) * | 2010-02-18 | 2011-08-25 | The Board Of Trustees Of The University Of Illinois | Methods for forming protected organoboronic acids |
| US10500178B2 (en) | 2015-03-13 | 2019-12-10 | The Board Of Trustees Of The Leland Stanford Junior University | LTB4 inhibition to prevent and treat human lymphedema |
| KR102807066B1 (ko) * | 2019-09-30 | 2025-05-15 | 주식회사 엘지화학 | 아민계 화합물 제조방법 |
| CN117384617B (zh) * | 2023-12-13 | 2024-03-29 | 中国石油大学(华东) | 一种耐盐型胍胶压裂液交联剂水溶液及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9119920D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| MX9300312A (es) * | 1992-01-23 | 1993-07-31 | Pfizer | Antagonistas benzopiranicos y relacionado de ltb. |
| ES2098547T3 (es) * | 1992-01-23 | 1997-05-01 | Pfizer | Benzopirano y otros antagonistas de ltb4 relacionados. |
| CZ100895A3 (en) * | 1992-10-21 | 1995-10-18 | Pfizer | Enantiomeric cis-3-(4,6-dihydroxychroman-3-ylmethyl)benzoic acids |
| RU95109929A (ru) * | 1992-10-21 | 1997-03-20 | Пфайзер Инк. (US) | Сульфонамидные производные, фармацевтическая композиция и способ лечения млекопитающих |
| WO1996011920A1 (en) * | 1994-10-13 | 1996-04-25 | Pfizer Inc. | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists |
| CA2202056A1 (en) * | 1994-10-13 | 1996-04-25 | Mark A. Dombroski | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists |
| US5539128A (en) * | 1994-11-30 | 1996-07-23 | Pfizer Inc. | Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline |
-
1997
- 1997-08-25 KR KR1019997002175A patent/KR100339164B1/ko not_active Expired - Fee Related
- 1997-08-25 UA UA99031394A patent/UA58520C2/uk unknown
- 1997-08-25 US US09/367,235 patent/US6096906A/en not_active Expired - Fee Related
- 1997-08-25 EA EA199900204A patent/EA002204B1/ru not_active IP Right Cessation
- 1997-08-25 NZ NZ334214A patent/NZ334214A/xx unknown
- 1997-08-25 DK DK97934679T patent/DK0925292T3/da active
- 1997-08-25 YU YU13299A patent/YU13299A/sh unknown
- 1997-08-25 EP EP97934679A patent/EP0925292B1/en not_active Expired - Lifetime
- 1997-08-25 PL PL97332351A patent/PL332351A1/xx unknown
- 1997-08-25 DE DE69724801T patent/DE69724801T2/de not_active Expired - Fee Related
- 1997-08-25 SK SK313-99A patent/SK31399A3/sk unknown
- 1997-08-25 BR BR9711482A patent/BR9711482A/pt not_active Application Discontinuation
- 1997-08-25 WO PCT/IB1997/001024 patent/WO1998011085A1/en not_active Ceased
- 1997-08-25 JP JP10513430A patent/JP3117730B2/ja not_active Expired - Fee Related
- 1997-08-25 CA CA002265043A patent/CA2265043C/en not_active Expired - Fee Related
- 1997-08-25 PT PT97934679T patent/PT925292E/pt unknown
- 1997-08-25 CN CN97197985A patent/CN1108298C/zh not_active Expired - Fee Related
- 1997-08-25 ES ES97934679T patent/ES2206738T3/es not_active Expired - Lifetime
- 1997-08-25 AT AT97934679T patent/ATE249452T1/de not_active IP Right Cessation
- 1997-08-25 TR TR1999/00592T patent/TR199900592T2/xx unknown
- 1997-08-25 AU AU37814/97A patent/AU713701B2/en not_active Ceased
- 1997-08-25 IL IL12873297A patent/IL128732A0/xx unknown
- 1997-08-29 HN HN1997000127A patent/HN1997000127A/es unknown
- 1997-09-04 CO CO97051475A patent/CO4600635A1/es unknown
- 1997-09-05 PA PA19978437901A patent/PA8437901A1/es unknown
- 1997-09-08 GT GT199700104A patent/GT199700104A/es unknown
- 1997-09-11 AP APAP/P/1997/001083A patent/AP726A/en active
- 1997-09-12 TW TW086113297A patent/TW449579B/zh active
- 1997-09-12 PE PE1997000813A patent/PE109798A1/es not_active Application Discontinuation
- 1997-09-15 MA MA24797A patent/MA24319A1/fr unknown
- 1997-09-15 TN TNTNSN97155A patent/TNSN97155A1/fr unknown
- 1997-09-15 ID IDP973183A patent/ID19613A/id unknown
- 1997-09-15 DZ DZ970158A patent/DZ2308A1/xx active
- 1997-09-15 ZA ZA978291A patent/ZA978291B/xx unknown
- 1997-09-16 HR HR970497A patent/HRP970497B1/xx not_active IP Right Cessation
- 1997-10-04 GT GT199700104BL patent/GT199700104BA/es unknown
- 1997-10-04 GT GT199700104AK patent/GT199700104AA/es unknown
-
1999
- 1999-02-16 IS IS4980A patent/IS4980A/is unknown
- 1999-03-09 BG BG103231A patent/BG63542B1/bg unknown
- 1999-03-12 OA OA9900056A patent/OA10995A/en unknown
- 1999-03-15 NO NO991254A patent/NO991254L/no not_active Application Discontinuation
-
2000
- 2000-02-23 US US09/511,475 patent/US6288242B1/en not_active Expired - Fee Related
-
2001
- 2001-03-21 US US09/813,546 patent/US6355825B1/en not_active Expired - Fee Related
- 2001-10-31 US US09/999,240 patent/US6444826B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT199700124A (es) | Derivados de aminas biciclicas | |
| GT199700104AA (es) | Procedimientos e intermedios para preparar derivados de cromanol sustituidos | |
| GT199800077A (es) | Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4" sustituidos. | |
| GT199800075A (es) | Derivados de macrolidos c-4" sustituidos. | |
| GT199700089A (es) | Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido. | |
| GT199800106A (es) | Azetidinas. | |
| GT199700079A (es) | Derivados triciclos sustituidos con fenilamino | |
| GT199700141A (es) | Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas. | |
| ES2045110T3 (es) | Mejoras en o relacionadas con antagonistas de leucotrienos. | |
| GT199800083A (es) | Agonistas de prostaglandinas. | |
| PA8461701A1 (es) | Derivados de 9-amino-3-ceto eritromicina | |
| GT200100007A (es) | Antagonistas del factor liberador de corticotropina. | |
| SV1999000016A (es) | Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv | |
| ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
| ES2053763T3 (es) | Composiciones estabilizadas de isotiazolonas. | |
| GT199800068A (es) | Procedimiento para la preparacion de nuevos derivados de triazole y los medicamentos que los contienen. | |
| CO5221025A1 (es) | 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contienen y su uso como agente para la lucha contra organismos daninos | |
| CO5210920A1 (es) | 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contienen y su uso como agente para la lucha contra organismos daninos | |
| PA8461401A1 (es) | Derivados de eritromicina triciclicos | |
| ES2177811T3 (es) | Uso de nitroflavonoides para el tratamiento de la ansiedad. | |
| AR030662A1 (es) | Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos | |
| ECSP034530A (es) | Derivados de 6-metil-tramadol sustituido en o | |
| GT199800081A (es) | Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para el tratamiento delcancer. | |
| AR005955A1 (es) | Derivados de pirazol-4-il-hetaroilo, procedimiento para su preparacion, composiciones herbicidas que los contienen y procedimiento para controlarel crecimiento de plantas indeseadas con la aplicacion de dichos compuestos | |
| ES2128191T3 (es) | Composiciones para el teñido por oxidacion de fibras queratinicas y procedimiento de teñido que las utiliza. |